PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
2.960
-0.140 (-4.52%)
At close: Aug 15, 2025, 4:00 PM
3.010
+0.050 (1.69%)
After-hours: Aug 15, 2025, 5:08 PM EDT
PetMed Express Revenue
PetMed Express had revenue of $52.98M in the quarter ending December 31, 2024, a decrease of -18.88%. This brings the company's revenue in the last twelve months to $247.01M, down -10.82% year-over-year. In the fiscal year ending March 31, 2024, PetMed Express had annual revenue of $281.06M with 9.54% growth.
Revenue (ttm)
$247.01M
Revenue Growth
-10.82%
P/S Ratio
0.26
Revenue / Employee
$860,662
Employees
287
Market Cap
61.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 281.06M | 24.49M | 9.54% |
| Mar 31, 2023 | 256.58M | -15.70M | -5.77% |
| Mar 31, 2022 | 272.28M | -31.30M | -10.31% |
| Mar 31, 2021 | 303.58M | 19.46M | 6.85% |
| Mar 31, 2020 | 284.13M | 706.00K | 0.25% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PETS News
- 3 days ago - PetMed Express, Inc. Announces Management Changes - GlobeNewsWire
- 6 weeks ago - PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - GlobeNewsWire
- 6 weeks ago - PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing - GlobeNewsWire
- 2 months ago - PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 - GlobeNewsWire
- 2 months ago - PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call - GlobeNewsWire
- 2 months ago - PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call - GlobeNewsWire
- 3 months ago - PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets - GlobeNewsWire
- 4 months ago - PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th - GlobeNewsWire